Lilly Just Placed Million Bet on Injectables Boom
Lilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
Discover user-friendly retirement planning software designed to simplify your financial planning and help you achieve your goals.
18,437 articlesLilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
Investors are buzzing about Micron Technology as AI and data-center demand shift the memory market. This article expl...
AI’s power needs are lifting uranium miners into mainstream focus, aided by the URA ETF as nuclear energy gains renew...
Eli Lilly shares surged to fresh highs, underpinned by upbeat analyst notes and strong pipeline momentum. This guide ...
A crypto treasury firm AVAX faced Nasdaq scrutiny but bounced back after a strategic reverse split. This article brea...
SpaceX is growing fast, but its financing moves could change the risk profile for investors. This article breaks down...
As the Fed hints at slower rate moves, crypto markets stir. This guide explains what the federal reserve signals good...
Intel stock looks beaten in the near term, but long-term possibilities remain. This guide breaks down the factors tha...
What if a $1,000 bet on COSTCO in 2006 rode all the way to today? This article breaks down the math, compares it to t...
XOVR, the $1.5 billion ETF that blends pre-IPO SpaceX exposure with public-growth stocks, is drawing renewed scrutiny...
Starting with $1,000 doesn’t limit your ability to build lasting passive income. This guide presents two dependable d...
Aggressive investors chase big upside, and sofi's next breakout: leveraged exposure promises amplified moves. This gu...